Epidemiology of Alzheimer's disease.

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Epidemiologic studies of disease fall into two large categories: descriptive and analytic. Both approaches have been used in studies of dementia and Alzheimer's disease (AD). The prevalence of dementia in persons age 65 and older in North America is approximately 6 to 10%, with AD accounting for two-thirds of these cases. If milder cases are included, the prevalence rates double. Only age and family history of dementia are consistently associated with AD in all studies, but putative protective agents such as estrogen, NSAIDs, and vitamin E are undergoing clinical trials.

Original languageEnglish
JournalGeriatrics
Volume52 Suppl 2
StatePublished - Sep 1997

Fingerprint

Dementia
Alzheimer Disease
Epidemiology
Protective Agents
Non-Steroidal Anti-Inflammatory Agents
North America
Vitamin E
Epidemiologic Studies
Estrogens
Clinical Trials
Alzheimer Disease 10

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Epidemiology of Alzheimer's disease. / Hendrie, Hugh.

In: Geriatrics, Vol. 52 Suppl 2, 09.1997.

Research output: Contribution to journalArticle

@article{dc0044456cbd4cd0a71929ebc534bcb1,
title = "Epidemiology of Alzheimer's disease.",
abstract = "Epidemiologic studies of disease fall into two large categories: descriptive and analytic. Both approaches have been used in studies of dementia and Alzheimer's disease (AD). The prevalence of dementia in persons age 65 and older in North America is approximately 6 to 10{\%}, with AD accounting for two-thirds of these cases. If milder cases are included, the prevalence rates double. Only age and family history of dementia are consistently associated with AD in all studies, but putative protective agents such as estrogen, NSAIDs, and vitamin E are undergoing clinical trials.",
author = "Hugh Hendrie",
year = "1997",
month = "9",
language = "English",
volume = "52 Suppl 2",
journal = "Geriatrics",
issn = "0016-867X",
publisher = "Advanstar Communications",

}

TY - JOUR

T1 - Epidemiology of Alzheimer's disease.

AU - Hendrie, Hugh

PY - 1997/9

Y1 - 1997/9

N2 - Epidemiologic studies of disease fall into two large categories: descriptive and analytic. Both approaches have been used in studies of dementia and Alzheimer's disease (AD). The prevalence of dementia in persons age 65 and older in North America is approximately 6 to 10%, with AD accounting for two-thirds of these cases. If milder cases are included, the prevalence rates double. Only age and family history of dementia are consistently associated with AD in all studies, but putative protective agents such as estrogen, NSAIDs, and vitamin E are undergoing clinical trials.

AB - Epidemiologic studies of disease fall into two large categories: descriptive and analytic. Both approaches have been used in studies of dementia and Alzheimer's disease (AD). The prevalence of dementia in persons age 65 and older in North America is approximately 6 to 10%, with AD accounting for two-thirds of these cases. If milder cases are included, the prevalence rates double. Only age and family history of dementia are consistently associated with AD in all studies, but putative protective agents such as estrogen, NSAIDs, and vitamin E are undergoing clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0031228830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031228830&partnerID=8YFLogxK

M3 - Article

C2 - 9307577

AN - SCOPUS:0031228830

VL - 52 Suppl 2

JO - Geriatrics

JF - Geriatrics

SN - 0016-867X

ER -